School of Medicine
Showing 701-750 of 911 Results
-
Nathan Lo
Assistant Professor of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsOur research laboratory is interested in studying the transmission of infectious diseases and impact of public health interventions with an ultimate goal of informing public health policy. We study a diverse set of pathogens, both domestically and internationally, including vaccine-preventable infections (including COVID-19) and neglected tropical diseases (such as schistosomiasis). Our group applies diverse computational methodologies, including tools of epidemiology, modeling, and policy analysis.
A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected tropical diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health. Nathan served as the lead writer of the World Health Organization guidelines on schistosomiasis (2022) and strongyloidiasis.
Our current research focuses on the following areas:
(1) Vaccine-preventable infectious diseases (including COVID-19) in the United States, with a focus on studying vaccines and transmission dynamics
(2) Public health strategies for control and elimination of globally important neglected infectious diseases, such as helminths infections (schistosomiasis, strongyloidiasis) and typhoid fever
Hiring
We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu. -
TZU HAN LO
Postdoctoral Scholar, Gastroenterology
BioTzu-Han Lo, a researcher at the Institute of Biomedical Sciences at Academia Sinica, has made contributions to the field of macrophage biology. His work has particularly focused on inflammation, especially in the context of fibrotic response. One of his works includes a study on the regulation of macrophage polarization in ureteral obstruction. This research has illuminated the role of inflammatory cell infiltration and activation during the early stages of kidney injury, a common pathological feature of chronic kidney disease.
In addition to his work on macrophage biology, Tzu-Han Lo has also delved into research related to galectins, a family of β-galactoside–binding proteins. His work in this area has centered on the role of galectins in recognizing microbial glycans, particularly lipopolysaccharides (LPSs). He has explored their impact on host defense mechanisms, including autophagy and both canonical and non-canonical inflammasome signaling pathways.
His research has offered insights into the complex interactions between host immunity and microbial components. This has contributed to our understanding of inflammatory responses and their implications for human health. -
James Lock
Eric Rothenberg, MD Professor and Professor, by courtesy, of Pediatrics
Current Research and Scholarly InterestsJames Lock, MD, Ph.D. is Professor of Child Psychiatry and Pediatrics in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has taught since 1993. He is board certified in adult as well as child and adolescent psychiatry. He directs the eating disorder program in Child Psychiatry and is active in treatment research for children and adolescents with eating disorders.
-
Michael Loecher
Physical Science Research Scientist, Rad/Radiological Sciences Laboratory
BioMy research focuses primarily on improving methods for measuring flow and motion with MRI. My research interests range from image acquisition and reconstruction to error correction and post processing strategies.
-
Andreas Loening
Assistant Professor of Radiology (Body MRI)
Current Research and Scholarly InterestsMy lab focuses on expanding the capability of MR and PET/MR as it relates to applications in body imaging. Clinical research aims include the application of new or improved MR sequences to increase the speed, robustness, and diagnostic capability of body MR. Translation research aims include exploring new MR contrast mechanisms and contrast agents, such as for the stratification of cancer within the prostate and the evaluation of the lymphatic system.
-
Juanita S. Loftus
Clinical Instructor, Pediatrics - General Pediatrics
BioClinical Focus
____
Pediatrics
Academic Appointment
____
Clinical Instructor, General Pediatrics
Professional Education
_____
Board Certification: American Board of Pediatrics, Pediatrics (1989)
Residency: St. Louis Children's Hospital, St. Louis, MO (1989)
Medical Education: Washington University School of Medicine, St. Louis, MO (1986) -
Daniel S Logan
Research Data Analyst 1, Stanford-Surgery Policy Improvement Research and Education Center
BioDaniel Logan is a Research Data Analyst with the Stanford-Surgery Policy Improvement Research & Education Center (S-SPIRE). Daniel obtained a bachelors degree in Sociology from Bates College as well as a bootcamp diploma in Data Science. He has experience with a variety quantitative and qualitative research methodologies, making him unique situated for mixed methods research. As a research data analyst, he puts this background to use for machine learning optimization, data management, and general analytics for clinical and observational studies.
-
Kyle Loh
Assistant Professor of Developmental Biology (Stem Cell)
BioHow the richly varied cell-types in the human body arise from one embryonic cell is a biological marvel and mystery. We have mapped how human embryonic stem cells develop into over twenty different human cell-types. This roadmap allowed us to generate enriched populations of human liver, bone, heart and blood vessel precursors in a Petri dish from embryonic stem cells. Each of these tissue precursors could regenerate their cognate tissue upon injection into respective mouse models, with relevance to regenerative medicine. In addition to our interests in developmental and stem cell biology, we also interested in discovering the entry receptors and target cells of deadly biosafety level 4 viruses, together with our collaborators.
Kyle attended the County College of Morris and Rutgers University, and received his Ph.D. from Stanford University (working with Irving Weissman), with fellowships from the Hertz Foundation, National Science Foundation and Davidson Institute for Talent Development. He then continued as a Siebel Investigator, and later, as an Assistant Professor and The Anthony DiGenova Endowed Faculty Scholar at Stanford, where he is jointly appointed in the Department of Developmental Biology and Institute for Stem Cell Biology & Regenerative Medicine. Kyle is a Packard Fellow, Pew Scholar, Human Frontier Science Program Young Investigator and Baxter Foundation Faculty Scholar, and his research has been recognized by the NIH Director's Early Independence Award, Forbes 30 Under 30, Harold Weintraub Graduate Award, Hertz Foundation Thesis Prize and A*STAR Investigatorship. -
Martin J. Lohse
Visiting Professor, Molecular & Cellular Physiology
BioMartin Lohse studied medicine and philosophy at the universities of Göttingen (Germany), London (UK) and Paris (France). From 1978 to 1981 he did his MD thesis in the Department of Neurobiology at the Max Planck Institute of Biophysical Chemistry with Otto Creutzfeldt and Wolfgang Wuttke investigating the central nervous system effects of endogenous opiates. He was a postdoc in pharmacology with Ulrich Schwabe at the University of Heidelberg, and then with Robert J. Lefkowitz (HHMI, Duke University), where he later became an Assistant Professor. From Duke he moved to his first independent lab at the Gene Center in Munich/Martinsried, a new research center operated jointly by the Max Planck Institute for Biochemistry and the University of Munich. In 1993, he became Chair of the Institute of Pharmacology and Toxicology at the University of Würzburg, and remained a professor at this university until his retirement in 2022. In Würzburg, he founded the Rudolf Virchow Center, the DFG Research Center for Experimental Biomedicine (2001-2016), and he became also the founding director of the University of Würzburg Graduate School (2003-2016).
From 2016 to 2019 he served as Chairman of the Max Delbrück Center in Berlin, a national research center for molecular medicine. In 2020, while keeping his lab in Berlin, he moved back to Bavaria to establish and lead the new start-up institute/incubator ISAR Bioscience in Munich/Planegg, that aims to use stem cell technologies to advance academic projects towards clinical applications and to foster the formation of start-up companies.
Martin Lohse has accepted many public and professional service duties. He was a member of the German National Ethics Council, Vice President for Research of the University of Würzburg, Vice President of the German National Academy of Sciences Leopoldina, and President of the Society of German Natural Scientists and Physicians GDNÄ. He has been a member and chair of numerous scientific advisory boards across Europe. He holds honorary, senior and distinguished professorships at the Free University of Berlin, the University of Leipzig, and the Technical University of Munich TUM. At the Department for Molecular and Cellular Physiology of Stanford University he collaborates with the teams of Brian Kobilka and Ruth Hüttenhain to probe the local environment of receptors and its function and regulation. -
Renske Lok
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsI'm interested in questions regarding perceived experiences and measured markers of those experiences, for example how do perceived sleep quality relate to sleep quality measured, or how does daytime sleepiness relate to sleep quality at night.
Other interests include effects of daytime light exposure on nighttime sleep, circadian clock phase changes by flashes of light, and how stability and variability in daily rhythms can predict health and disease -
Adrienne H. Long, MD, PhD
Instructor, Pediatrics - Hematology & Oncology
BioAdrienne H. Long, MD, PhD is an instructor in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital at Stanford. Dr. Long attend Northwestern University, where she earned both her BS in biomedical engineering and her MD. Determined to help develop novel treatments for pediatric cancer patients, she took time during medical school to pursue a PhD at the National Institutes of Health (NIH), where she helped advance CAR T cell therapies with Dr. Crystal Mackall. Her influential thesis work was the first to identify T cell exhaustion as a critical factor limiting efficacy of CAR therapies (Long et al., Nature Medicine, 2015), and also identified novel methods to enhance CAR therapies for pediatric solid tumor patients (Long/Highfill et al., Cancer Immunology Research, 2016). Dr. Long went on to complete her pediatrics residency training at Boston Children’s Hospital, where she continued her research in cancer immunology with Dr. Nicholas Haining – this time focusing on strategies to enhance antigen presentation to augment checkpoint blockade (Long et al. Keystone Symposium on Cancer Immunotherapy, 2019). She completed her pediatric oncology fellowship at Stanford, and remains dedicated to a career as a physician-scientist focused on developing novel immunotherapies for children with cancer. She is currently conducting her post-doctoral research with Dr. Mark Davis, studying how thymic selection, designed to prevent auto-immunity, may also inhibit antitumor immunity in children.
-
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies signaling pathways in mammalian energy metabolism. The long-term goal of this program is to discover new molecules and pathways that can be translated into therapeutic opportunities for obesity, metabolic disease, and other age-associated chronic diseases. Work from the laboratory has been recognized by numerous awards from the Alfred P. Sloan Foundation, the National Institutes of Health, the American Diabetes Association, and the Ono Pharma Foundation. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Sharon R. Long
William C. Steere, Jr. - Pfizer Inc. Professor of Biological Sciences and Professor, by courtesy, of Biochemistry
Current Research and Scholarly InterestsBiochemistry, genetics and cell biology of plant-bacterial symbiosis
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
On Leave from 09/01/2023 To 05/16/2024Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Dr. Michael T. Longaker
Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsWe have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.
-
Frank M. Longo, MD, PhD
George E. and Lucy Becker Professor of Medicine and Professor, by courtesy, of Neurosurgery
On Partial Leave from 05/01/2024 To 07/31/2024Current Research and Scholarly InterestsClinical interests include Alzheimer's disease and Huntington's disease and the development of effective therapeutics for these disorders. Laboratory interests encompass the elucidation of signaling mechanisms relevant to neurodegenerative disorders and the development of novel small molecule approaches for the treatment of neurodegenerative and other neurological disorders.
-
James Longoria, MD
Clinical Associate Professor, Cardiothoracic Surgery
BioDr. Longoria is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical associate professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
Deeply accomplished in all facets of complex adult cardiothoracic procedures, Dr. Longoria is a high-volume surgeon with more than 20 years of experience and an exceptionally low mortality and complication rate.
Dr. Longoria’s surgical experience includes complex mitral valve and tricuspid valve repair, coronary artery bypass grafting, adult congenital repair, as well as procedures for high risk VAD patients. He performs cardiac transplantation, carotid endarterectomy, and implantation of all FDA-approved mechanical circulatory support devices. Additionally, he performs catheter-based valvular procedures (such as transcatheter aortic valve replacement, or TAVR) and open and video-assisted thoracoscopic surgery (VATS) for pulmonary surgical procedures.
He has an applied interest in atrial fibrillation (AFib) and is a nationally recognized expert in the minimally invasive surgical treatment of Atrial Fibrillation (AFib). Dr. Longoria was issued a method patent from the U.S. Patent and Trademark Office for developing the TTMaze (Totally Thoracoscopic) procedure that is central to the Dual Epicardial Endocardial Persistent (DEEP) AFib clinical trial.
Before joining Stanford, Dr. Longoria was the surgical director of cardiac ablation at a prominent AFib center certified by the Society of Chest Pain Centers. He holds patents for a synthetic chord used to connect tissue and for specialized methods he developed to treat cardiac arrhythmias.
At Stanford, Dr. Longoria brings a commitment to patientcentric, personalized care. He is committed to making the experience of surgery as pleasant as possible for his patients. He is also excited for the opportunity to conduct translational research that utilizes the most advanced technology available, in collaboration with colleagues from other disciplines.
For his outcomes and high patient satisfaction ratings, Dr. Longoria has earned awards and recognition, including being named a Top Doctor of Sacramento by his peers for the last five years in a row. He has also been an honoree of the President’s Award for patient satisfaction by the Sutter Independent Physicians.
Dr. Longoria has published articles on genetic variants associated with atrial fibrillation, thoracoscopic left atrial appendage clipping, radiofrequency ablation, and other topics. His work has appeared in the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of the American College of Cardiology, Journal of Cardiovascular Electrophysiology, and elsewhere.
He has made numerous presentations on atrial fibrillation surgery and other topics at conferences including the Annual Meeting of the American Association of Thoracic Surgery, Society of Thoracic Surgeons, and International Society for Heart and Lung Transplantation.
Dr. Longoria is a Fellow of the American College of Surgeons and American College of Cardiology. He is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, the International Society for Minimally Invasive Cardiothoracic Surgery, and the Heart Rhythm Society. -
Billy W Loo, Jr, MD PhD FASTRO FACR
Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy clinical specialty is radiation treatment of thoracic cancers.
My research is on developing next-generation ultra-rapid radiation therapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.
My clinical research is on advanced 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers.
